Great-West Lifeco Inc. (TSE:GWO – Get Free Report) insider Jean-Francois Poulin sold 19,800 shares of the stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of C$79.57, for a total transaction of C$1,575,486.00. Following the completion of the transaction, the insider owned 160 shares in the company, valued at C$12,731.20. This trade represents a 99.20% decrease in their position.
Great-West Lifeco Stock Performance
Shares of TSE:GWO traded down C$0.05 during trading on Monday, hitting C$79.35. The company’s stock had a trading volume of 181,574 shares, compared to its average volume of 1,616,611. The company has a 50-day moving average of C$69.88 and a 200-day moving average of C$66.30. Great-West Lifeco Inc. has a 12 month low of C$49.78 and a 12 month high of C$79.96. The company has a debt-to-equity ratio of 29.59, a current ratio of 6.57 and a quick ratio of 22.18. The firm has a market cap of C$71.26 billion, a price-to-earnings ratio of 17.06, a P/E/G ratio of 2.26 and a beta of 0.59.
Great-West Lifeco (TSE:GWO – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported C$1.37 earnings per share for the quarter. Great-West Lifeco had a net margin of 12.86% and a return on equity of 15.17%. The firm had revenue of C$8.37 billion for the quarter. On average, sell-side analysts expect that Great-West Lifeco Inc. will post 4.4525194 earnings per share for the current year.
Great-West Lifeco Increases Dividend
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on GWO shares. Desjardins increased their price objective on shares of Great-West Lifeco from C$71.00 to C$80.00 and gave the stock a “hold” rating in a research note on Friday, May 8th. Royal Bank Of Canada increased their price objective on shares of Great-West Lifeco from C$64.00 to C$77.00 in a research note on Friday, May 8th. Jefferies Financial Group increased their price objective on shares of Great-West Lifeco from C$70.00 to C$83.00 in a research note on Friday, May 1st. BMO Capital Markets raised their target price on shares of Great-West Lifeco from C$70.00 to C$76.00 in a research note on Friday, May 8th. Finally, Barclays raised their target price on shares of Great-West Lifeco from C$70.00 to C$73.00 in a research note on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Great-West Lifeco has a consensus rating of “Moderate Buy” and an average target price of C$77.18.
View Our Latest Report on Great-West Lifeco
About Great-West Lifeco
Great-West Lifeco is one of the three big Canadian life insurance firms. With just under half of the firm’s profit and revenue in Canada, Great-West also operates in the U.S. and Europe. In Canada, Great-West provides both individual and group insurance. In the United States, Great-West operates Putnam Investments and defined-contribution recordkeeping firm Empower Retirement. In 2020, Great-West announced it would acquire Personal Capital and MassMutual’s recordkeeping business. In Europe, Great-West offers life insurance, annuities, and reinsurance primarily in the U.K., Ireland, and Germany.
See Also
- Five stocks we like better than Great-West Lifeco
- SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
- Microsoft Stock Discount May Be Ending as AI Catalysts Build
- Apparel Earnings Winners and Losers: Ralph Lauren Takes Off
- Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Receive News & Ratings for Great-West Lifeco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Great-West Lifeco and related companies with MarketBeat.com's FREE daily email newsletter.
